Home
>
US Stocks
>
Fusion Pharmaceuticals Inc
Fusion Pharmaceuticals Inc
FUSN

Fusion Pharmaceuticals Inc (FUSN)

$7.316%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
7.5
Today Low/High
7.3 / 7.5
52 Week Low/High
$6.61 / $13.89
Market Cap
$351.47M

Company Details

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Fusion connects alpha particle emitting isotopes to targeting molecules in order to selectively deliver the alpha emitting payloads to tumors. Fusion's lead program, FPI-1434, is currently in a Phase 1 clinical trial. The Company is advancing a pipeline of targeted radiopharmaceutical cancer therapies for a broad array of tumor types based upon its proprietary platform technology.
Organisation
Fusion Pharmaceuticals Inc
Employees
61
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Fusion Pharmaceuticals Inc (FUSN) share price today?

Can Indians buy Fusion Pharmaceuticals Inc (FUSN) shares?

How can I buy Fusion Pharmaceuticals Inc (FUSN) shares from India?

Can Fractional shares of Fusion Pharmaceuticals Inc (FUSN) be purchased?

What are the documents required to start investing in Fusion Pharmaceuticals Inc (FUSN) stocks?

We are a SEBI registered investement advisor